Sarepta Therapeutics’ Strategic Alliance with Arrowhead Pharmaceuticals Secures Future Growth
William Blair analyst Sami Corwin has maintained their bullish stance on SRPT stock, giving a Buy rating today.Don't Miss our Black Friday ...
腾讯网46 分钟
超100亿美元！新锐联手推动十余个RNAi研发项目
Sarepta Therapeutics今日宣布与Arrowhead ...